Sulphasalazine therapy in rheumatoid arthritis: qualitative changes in lymphocytes and correlation with clinical response.

@article{Samanta1992SulphasalazineTI,
  title={Sulphasalazine therapy in rheumatoid arthritis: qualitative changes in lymphocytes and correlation with clinical response.},
  author={Ash Samanta and Cynthia Webb and K. A. Grindulis and Joseph Fleming and Pauline J. Sheldon},
  journal={British journal of rheumatology},
  year={1992},
  volume={31 4},
  pages={259-63}
}
Clinical and immunological parameters in 14 patients with rheumatoid arthritis (RA) receiving sulphasalazine (SASP) were evaluated, to determine whether their clinical response was reflected by any quantitative changes in their peripheral blood lymphocytes after 12 weeks. Whilst disease activity markers fell significantly, no such changes were noted in the percentage or absolute numbers of lymphocytes or their subsets. The lymphocytes of a further 21 patients before and after receiving SASP for… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.